PMID: 9534938Apr 16, 1998Paper

Effect of disruption of the cytoskeleton on smooth muscle contraction

Canadian Journal of Physiology and Pharmacology
A S Battistella-PattersonG L Wright

Abstract

The relationship between passive tension applied to aortic rings and the resulting increase in tissue length was nearly linear over the range of 1 to 15 g. However, even with increasing tissue length, within the range of 1 to 10 g passive tension, the total active force generated upon stimulation was not significantly changed. These observations emphasize the great flexibility of the mechanism(s) underlying the contractile response of vascular smooth muscle with regard to changes in tissue preload and length. Neither the blockade of microtubule polymerization by colchicine nor the blockade of actin polymerization by cytochalasin B significantly changed the slope of the tissue length-preload curve, indicating no effect on the tissues' capacity to stretch at a given preload. With stimulation of the tissue at different levels of stretch, colchicine caused an increase in the initial fast component of active tension development, but partially blocked the secondary slow rise in tension. Cytochalasin B dramatically reduced the total contractile response at each preload studied, and this effect was confined almost exclusively to the secondary slow increase in tension. When tissues were cooled to cause complete dissolution of the microt...Continue Reading

References

Feb 10, 1992·FEBS Letters·R G Burns
Apr 1, 1988·Canadian Journal of Physiology and Pharmacology·B S HuangG L Wright
Jan 1, 1989·Annual Review of Physiology·R A Murphy
Jan 1, 1989·Annual Review of Physiology·C M Hai, R A Murphy
Jan 1, 1986·The Journal of Cell Biology·J V SmallJ De Mey
Sep 1, 1986·The Journal of Cell Biology·R L BallW C Thompson
Dec 1, 1974·The Journal of General Physiology·R A MurphyJ Megerman
Oct 1, 1970·The Journal of Cell Biology·R V RiceL M Blasik
Sep 1, 1973·Circulation Research·J T Herlihy, R A Murphy
May 1, 1966·The Journal of Physiology·A M GordonF J Julian
Jan 1, 1995·The Journal of General Physiology·V R PratusevichL E Ford
Apr 1, 1994·European Journal of Pharmacology·K Obara, H Yabu
Feb 1, 1994·Current Opinion in Cell Biology·M A Hoyt
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·P VanBurenD M Warshaw
Jan 1, 1993·Annual Review of Biochemistry·R A Walker, M P Sheetz

❮ Previous
Next ❯

Citations

Sep 11, 2002·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·José Pedro L Nunes
Jul 4, 2008·American Journal of Physiology. Cell Physiology·Hak Rim KimKathleen G Morgan
Aug 4, 2009·Journal of Biomechanics·S RoyN Stergiopulos
Jan 25, 2005·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Marina V NechaevaNadezhda P Zhdanova
Jan 23, 2008·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Svetlana V KoltsovaSergei N Orlov
May 10, 2011·Journal of Pharmacological Sciences·Sean E ThatcherKazuhiro Kohama
Feb 1, 2003·Acta Physiologica Scandinavica·M E Fultz, G L Wright

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.